Latest Lipid Stories
DARTMOUTH, NS, May 2 /PRNewswire/ - The American Heart Association (AHA) recently issued its first ever statement on triglyceride management that includes recommendations for Omega-3 EPA/DHA intake.Â Elevated triglyceride levels have long been associated with cardiovascular disease (CVD).Â According to the AHA more than 31% of the United States population has borderline high triglyceride levels.Â Furthermore, AHA's 2006 statistical data estimates that 81,100,000Â people in...
Statement Highlights: - Diet and lifestyle changes that include substituting healthy fats for unhealthy saturated and trans fats, engaging in regular physical activity and losing excess weight can reduce triglycerides - a blood fat - by 20 percent to 50 percent. - New clinical recommendations include reducing the optimal triglyceride level from <150 mg/dL to <100 mg/dL, and performing non-fasting triglyceride testing as an initial screen. DALLAS, April 18, 2011...
A new pathway has been discovered that links a common dietary lipid and intestinal microflora with an increased risk of heart disease.
Researchers have identified a molecular switch that appears to be a common feature in the development of fatty liver disease.
SEATTLE, March 25, 2011 /PRNewswire-USNewswire/ -- A study of Yup'ik Eskimos in Alaska, who on average consume 20 times more omega-3 fats from fish than people in the lower 48 states, suggests that a high intake of these fats helps prevent obesity-related chronic diseases such as diabetes and heart disease. The study, led by researchers at Fred Hutchinson Cancer Research Center and conducted in collaboration with the Center for Alaska Native Health Research at the University of...
Women who consume fish and Omega-3 fatty acids on a regular basis are less likely to develop age-related macular degeneration (AMD).
Regular consumption of fish and omega-3 fatty acids found in fish is associated with a significantly reduced risk of developing age-related macular degeneration in women.
BEDMINSTER, N.J., March 14, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova(TM), the Company's lead compound for the treatment of patients with very high triglycerides.
FRESNO, Calif., Feb. 28, 2011 /PRNewswire/ -- Newly released research from Penn State University highlights phytosterols, found in pistachios, may improve cholesterol, a factor in cardiovascular health.
SAN DIEGO, Feb.
More Images (3 images) »